Modern Vascular Announces Hiring of Dr. Steve Berkowitz

Modern Vascular, a pioneering medical group dedicated to preventing amputation through the treatment of peripheral artery disease (PAD), today announced the hiring of Dr. Steve Berkowitz, a nationally recognized healthcare leader with over 25 years of experience in senior management, protocol standardization, and clinical oversight.

Previous Experience

Dr. Berkowitz comes to Modern Vascular from Banner Health in Phoenix, Arizona, where he served as the organization’s Medical Director of Specialty Performance Improvement. Prior to that position, he was the Chief Physician Executive and medical group president for Northern Light Health, a nine-hospital system in Maine. He’s also held the title of Chief Medical Officer at St. David’s Healthcare, a six-hospital system in Austin, Texas and at the Central and West Texas Division of HCA, which was awarded the Texas Award for Performance Excellence and the prestigious Malcolm Baldrige National Quality award.

“I am thrilled to join the Modern Vascular team,” Dr. Berkowitz said. “The organization is dedicated to saving patients from the unnecessary risk and cost associated with amputations. I have seen the work that is being done in their clinics and am convinced their treatments represent the gold-standard for PAD care. I was also impressed by Modern Vascular’s commitment to caring for underserved communities, especially indigenous populations in the American Southwest.”

Board Certified

Dr. Berkowitz, who is board certified in internal medicine, said he found Modern Vascular’s approach especially appealing because the procedures are minimally invasive, which means no general anesthesia and no surgery. This is particularly important given the typical age and health status of patients with peripheral artery disease. “Unfortunately, many patients are encouraged to undergo invasive vascular surgeries requiring hospitalization, and even amputations, a high-risk and life-altering surgery,” he added. “While amputations might be profitable for some practices, I believe patients and their quality-of-life matter more than profit. And I’m proud to work for a company with the mission of eliminating unnecessary amputations as the standard treatment for those with peripheral artery disease.”

New Role

In his new role, Dr. Berkowitz will ensure the best-in-class standards of care already in place at Modern Vascular clinics are enhanced, improved, and implemented as the company expands. He will also oversee the multidisciplinary panel of healthcare professionals employed by Modern Vascular, which includes Interventional Radiologists, Vascular Surgeons, and Interventional Cardiologists at the company’s 14 clinics nationwide.

“We are thrilled to welcome Dr. Berkowitz to the Modern Vascular family,” noted Dr. Yury Gampel, the company’s founder and CEO. “As the demand for our minimally invasive services continues to grow and we open more clinics across the country, it is imperative for Modern Vascular to have a full-time Chief Medical Officer who will be an advocate for innovative quality measures that improve the lives of our patients.”

Other Executives In the News

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Executives on the Move

Dr A Burton Tripathi brings over two decades of Medical Device leadership experience, specializing in developing disruptive technologies, leading commercialization efforts, and facilitating M&A. Having recently served as CEO of TrueVision Systems Inc., he concluded the sale and integration of TrueVision with Alcon.
John Taylor brings more than 30 years of regulatory experience to his role at ELIQUENT, including a distinguished 20-year career at the U.S. Food and Drug Administration (FDA), where he served in multiple leadership positions, including as FDA’s Acting Deputy Principal Commissioner, FDA Counselor to the Commissioner, Acting Deputy Commissioner for Global Regulatory Operations and Policy, and Associate Commissioner for Regulatory Affairs.
Jennifer Riter comes to Kindeva from West Pharmaceutical where she spent the past 27 years in various technical and leadership roles, most recently serving as the Senior Director, Business and Technical Operations.

By using this website you agree to accept Medical Device News Magazine Privacy Policy

Exit mobile version